Back to SO SOROS FUND MANAGEMENT LLC

SYRESYRE
Showing 4 of 6 quarters

Position history for SOSOROS FUND MANAGEMENT LLC's holdings in Spyre Therapeutics, Inc

SOROS FUND MANAGEMENT LLC previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$4.3M

Total Shares Change

-145,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$15.22
0
2025-Q1
Decreased
125,000
-50.0%
$2M0.0%$17.94
0
2024-Q4
Increased
250,000
+72.4%
$5.8M0.1%$22.54
41
2024-Q3
Unchanged
145,000
0.0%
$4.3M0.1%$28.49
0

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used